Vivozon Healthcare Inc
Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications. It also provides LED set linear lamps, including panel lamps, down lights, and flood lights for residential, commercial, and industrial structures, as w… Read more
Vivozon Healthcare Inc (082800) - Total Liabilities
Latest total liabilities as of September 2025: ₩82.73 Billion KRW
Based on the latest financial reports, Vivozon Healthcare Inc (082800) has total liabilities worth ₩82.73 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Vivozon Healthcare Inc - Total Liabilities Trend (2009–2024)
This chart illustrates how Vivozon Healthcare Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Vivozon Healthcare Inc Competitors by Total Liabilities
The table below lists competitors of Vivozon Healthcare Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Prince Pipes And Fittings Limited
NSE:PRINCEPIPE
|
India | ₹6.34 Billion |
|
Beijing Navigation Control Technology Co. Ltd.
SHG:688282
|
China | CN¥227.23 Million |
|
Fennec Pharmaceuticals Inc
NASDAQ:FENC
|
USA | $53.70 Million |
|
Ningbo Peace Bird Fashion
SHG:603877
|
China | CN¥3.29 Billion |
|
Southeast Cement Co Ltd
TW:1110
|
Taiwan | NT$3.10 Billion |
|
Seetel New Energy Co., Ltd.
TW:7740
|
Taiwan | NT$8.10 Billion |
|
Fireweed Zinc Ltd
OTCQX:FWEDF
|
USA | $15.54 Million |
Liability Composition Analysis (2009–2024)
This chart breaks down Vivozon Healthcare Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.94 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.49 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Vivozon Healthcare Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Vivozon Healthcare Inc (2009–2024)
The table below shows the annual total liabilities of Vivozon Healthcare Inc from 2009 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩78.02 Billion | +12.13% |
| 2023-12-31 | ₩69.58 Billion | -14.35% |
| 2022-12-31 | ₩81.24 Billion | -25.71% |
| 2021-12-31 | ₩109.35 Billion | -22.09% |
| 2020-12-31 | ₩140.36 Billion | +152.18% |
| 2019-12-31 | ₩55.66 Billion | +72.82% |
| 2018-12-31 | ₩32.21 Billion | +58.61% |
| 2017-12-31 | ₩20.31 Billion | +5.66% |
| 2016-12-31 | ₩19.22 Billion | -20.10% |
| 2015-12-31 | ₩24.05 Billion | +22.48% |
| 2014-12-31 | ₩19.64 Billion | -76.64% |
| 2010-12-31 | ₩84.07 Billion | +124.46% |
| 2009-12-31 | ₩37.45 Billion | -- |